Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384074310> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W4384074310 endingPage "231" @default.
- W4384074310 startingPage "224" @default.
- W4384074310 abstract "Asprosin was a novel adipokine that was released by white adipose tissue. It was activated by fasting and attracted to the liver, which allowed the liver to rapidly release glucose into the bloodstream. White adipose tissue was the source of asprosin. When people go on a fast, their blood sugar levels drop, which causes levels of the hormone asprosin to rise. It does this by binding to a G-protein-coupled receptor in the liver known as OR4M1, which in turn activates a cascade that involves the G -protein-cAMP-PKA pathway. Because of this, the glucose that is stored in the liver is released. We anticipate that by investigating the changes that occur in asprosin levels in hypothyroidism patients, we will be able to make a significant addition to the area and fill a gap that has been left unexplored in the anther researches. Eighty patients (women ) ranging in age from 25 to 65 were collected from the National Diabetes Center Al-Mustansiriyah University (Iraq) for the purpose of this study, which was designed as a cross-sectional study to determine the concentrations of serum ( asprosin, thyroid hormone T3 T4 TSH, Fasting blood glucose FBG, and lipid profile( Total cholesterol TCho,Triglycride TG,high density lipoprotein HDL, Low density lipoprotein LDL, Very low density lipoprotein VLDL) . In the period beginning in December 2021 and continuing until March 2022. This particular study included a total of 80 participants, 40 of whom had thyroid disease (hypothyroidism), and 40 healthy individuals who served as controls. When compared to the control group, the findings of this study indicate that the levels of total cholesterol TC, triglycerideTG, and low-density lipoprotein (LDL) have dramatically increased, whilst the levels of HDL have significantly decreased . A substantial increase in (Fasting blood glucose FBG and Body mass index BMI) levels was also observed, in contrast to the group that served as the control. In patients with hypothyroidism, the levels of thyroid-stimulating hormone TSH were considerably greater, while the levels of T3 were significantly lower. The T4 level, however, revealed no significant differences when compared to the control group. In addition, the level of asprosin was found to be high in the hypothyroidism group only contrast to the control group that participated in this research. 
 This current study indicates the hormone asprosin could be helpful early diagnosis in monitoring hypothyroidism patients. hormone asprosin is a marker of glucose homeostasis, so it may be surrogate novel biomarker for all other traditional biomarkers for the prediction of risk factors of diabetes and thyroid dysfunction" @default.
- W4384074310 created "2023-07-13" @default.
- W4384074310 creator A5002591010 @default.
- W4384074310 creator A5053907711 @default.
- W4384074310 creator A5092455070 @default.
- W4384074310 date "2023-04-20" @default.
- W4384074310 modified "2023-09-25" @default.
- W4384074310 title "Evaluation of Asprosin Hormone in Hypothyroidism Patients" @default.
- W4384074310 doi "https://doi.org/10.30526/36.2.3008" @default.
- W4384074310 hasPublicationYear "2023" @default.
- W4384074310 type Work @default.
- W4384074310 citedByCount "0" @default.
- W4384074310 crossrefType "journal-article" @default.
- W4384074310 hasAuthorship W4384074310A5002591010 @default.
- W4384074310 hasAuthorship W4384074310A5053907711 @default.
- W4384074310 hasAuthorship W4384074310A5092455070 @default.
- W4384074310 hasBestOaLocation W43840743101 @default.
- W4384074310 hasConcept C126322002 @default.
- W4384074310 hasConcept C134018914 @default.
- W4384074310 hasConcept C171089720 @default.
- W4384074310 hasConcept C194832188 @default.
- W4384074310 hasConcept C2778163477 @default.
- W4384074310 hasConcept C2780072125 @default.
- W4384074310 hasConcept C2780613262 @default.
- W4384074310 hasConcept C511355011 @default.
- W4384074310 hasConcept C526584372 @default.
- W4384074310 hasConcept C71315377 @default.
- W4384074310 hasConcept C71924100 @default.
- W4384074310 hasConceptScore W4384074310C126322002 @default.
- W4384074310 hasConceptScore W4384074310C134018914 @default.
- W4384074310 hasConceptScore W4384074310C171089720 @default.
- W4384074310 hasConceptScore W4384074310C194832188 @default.
- W4384074310 hasConceptScore W4384074310C2778163477 @default.
- W4384074310 hasConceptScore W4384074310C2780072125 @default.
- W4384074310 hasConceptScore W4384074310C2780613262 @default.
- W4384074310 hasConceptScore W4384074310C511355011 @default.
- W4384074310 hasConceptScore W4384074310C526584372 @default.
- W4384074310 hasConceptScore W4384074310C71315377 @default.
- W4384074310 hasConceptScore W4384074310C71924100 @default.
- W4384074310 hasIssue "2" @default.
- W4384074310 hasLocation W43840743101 @default.
- W4384074310 hasOpenAccess W4384074310 @default.
- W4384074310 hasPrimaryLocation W43840743101 @default.
- W4384074310 hasRelatedWork W2033292056 @default.
- W4384074310 hasRelatedWork W2062617116 @default.
- W4384074310 hasRelatedWork W2070380430 @default.
- W4384074310 hasRelatedWork W2078496896 @default.
- W4384074310 hasRelatedWork W2099969362 @default.
- W4384074310 hasRelatedWork W2106570883 @default.
- W4384074310 hasRelatedWork W2133032991 @default.
- W4384074310 hasRelatedWork W2299241988 @default.
- W4384074310 hasRelatedWork W2394176980 @default.
- W4384074310 hasRelatedWork W4247291053 @default.
- W4384074310 hasVolume "36" @default.
- W4384074310 isParatext "false" @default.
- W4384074310 isRetracted "false" @default.
- W4384074310 workType "article" @default.